Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial

Stopped early · Phase 3

Conditions studied: Percutaneous Coronary Intervention

In brief

The purpose of this trial is to determine whether bivalirudin is non-inferior to unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.

Key facts

Study ID

NCT02448550

Run by

Kaiser Permanente

People needed

250

Starts

2015-05-01

Expected to finish

2016-06-16

Last updated by the study team

2018-05-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing PCI for stable angina, unstable angina, or non-ST segment elevation myocardial infarction.
• Age 18 years or older.

You may not qualify if…

• Inability to obtain consent
• Emergency cardiac catheterization for ST-segment elevation myocardial infarction.

Where it is running

• Kaiser Permanente Los Angeles Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.